2010•British Journal of Clinical PharmacologyOpen access

Dabigatran etexilate

Eline A. Dubois, Adam F. Cohen

Open full text 9 citations

Abstract

In this series we draw attention to medicines that have entered the European market with an entirely new mechanism of action.

Open-access reader

About this research paper

What this paper is about

In this series we draw attention to medicines that have entered the European market with an entirely new mechanism of action.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In this series we draw attention to medicines that have entered the European market with an entirely new mechanism of action.

Key concepts: Dabigatran, Medicine, Direct thrombin inhibitor, Warfarin, Thrombin, Pharmacology, Antithrombins, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Dabigatran etexilate — Research Paper | ScholarLens